IP Library Granted Patent US 7,383,083
Granted Patent B2
US 7,383,083 · App. 10/820,553 · Granted Jun 3, 2008

Transdermal delivery system (TDS) with electrode network

Assignee: Novosis Pharma AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,383,083
App. No.
10/820,553
Granted
Jun 3, 2008
Kind
B2
Abstract

A transdermal delivery system (TDS) having: a carrier layer (cover layer) impermeable to the substances/active ingredients to be delivered, a membrane permeable to the substances/active ingredients to be delivered, a reservoir containing substances/active ingredients to be delivered, the reservoir being provided between the carrier layer and the membrane; and a removable film, wherein the carrier layer and the membrane comprise electrodes such that the electrode(s) of the membrane serve(s) as counterelectrode(s) to the electrode (the electrodes) of the carrier layer, is disclosed.

Claims (34)

1. A transdermal delivery system (TDS) comprising:

a carrier layer impermeable to a substance to be delivered and comprising one or more electrodes;

a reservoir containing said substance to be delivered, the reservoir formed by a contact adhesive and provided stacked between the carrier layer and one or more counter electrodes,

a removable film,

a battery,

an integrated controller microchip that is fixed to the carrier layer, and

a reading and writing device for writing onto the integrated controller microchip, wherein the one or more electrodes of the carrier layer are arranged in the form of one or more electrode network(s) on the carrier layer, each electrode network having a plurality of individual electrodes.

2. Delivery system according to claim 1 , wherein the carrier layer has a thickness in the range from 10 μm to 1000 μm.

3. Delivery system according to claim 1 , wherein the one or more electrodes of the carrier layer has/have been applied by printing.

4. Delivery system according to claim 1 , wherein there is a plurality of electrode networks, each electrode network is actuatable individually or a plurality of electrode networks are actuatable in groups and/or each individual electrode in a network is actuatable individually or a plurality of individual electrodes in a network are actuatable in groups.

5. Delivery system according to claim 1 , wherein the microchip is securely bonded to the carrier layer.

6. Delivery system according to claim 1 , wherein the microchip is a chip that is programmable according to a prescription.

7. Delivery system according to claim 1 , wherein the battery is a button battery or a sheet battery.

8. Delivery system according to claim 1 , wherein the battery is provided in a pocket in the carrier layer.

9. Transdermal delivery system (TDS), comprising:

a carrier layer impermeable to a substance to be delivered;

a membrane permeable to said substance to be delivered;

a reservoir containing said substance to be delivered, the reservoir being provided stacked between the carrier layer and the membrane;

a removable film;

a layer consisting of a pressure-sensitive contact adhesive applied to the side of the membrane remote from the reservoir;

a battery;

an integrated controller microchip fixed to the carrier layer; and

a reading and writing device for writing onto the integrated controller microchip,

wherein the carrier layer and the membrane comprise one or more electrodes such that the one or more electrodes of the membrane serve(s) as counterelectrode(s) to the one or more electrodes of the carrier layer, wherein the one or more electrodes of the carrier layer and/or of the membrane has/have been applied by printing.

10. Delivery system according to claim 9 , wherein the carrier layer has a thickness in the range from 10 μm to 1000 μm.

11. Delivery system according to claim 9 , wherein the substance reservoir comprises a contact adhesive, a gel or an immobilised solution for the substance to be delivered.

12. Delivery system according to claim 9 , wherein there is a plurality of electrode networks, each electrode network is actuatable individually or a plurality of electrode networks are actuatable in groups and/or each individual electrode in a network is actuatable individually or a plurality of individual electrodes in a network are actuatable in groups.

13. Delivery system according to claim 9 , wherein the membrane permeable to said substance is electrically conductive and is a metal lattice, or a polymer lattice on which a conductive layer has been vopour-deposited, or a perforated conductive layer.

14. Delivery system according to claim 9 , wherein the membrane permeable to said substance is electrically conductive and has uninterrupted conductivity or has conductive areas that are separated by non-conductive areas, so that one or more networks of conductive areas are formed.

15. Delivery system according to claim 14 , wherein each electrode of the carrier layer corresponds to a counterelectrode with which it is uniquely associated.

16. Delivery system according to claim 9 , wherein the microchip is securely bonded to the carrier layer.

17. Delivery system according to claim 9 , wherein the microchip is a chip that is programmable according to a prescription.

18. Delivery system according to claim 9 , wherein the battery is a button battery or a sheet battery.

19. Delivery system according to claim 9 , wherein the battery is provided in a pocket in the carrier layer.

Assignments (6)
CHANGE OF NAME Recorded Mar 20, 2017
From: ACINA AG
To: LUYE PHARMA AG
Reel/Frame 041653/0307 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF ASSIGNEE ACINO AG PREVIOUSLY RECORDED ON REEL 021968 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 28, 2009
From: NOVOSIS AG
To: ACINO AG
Reel/Frame 022162/0375 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE NOVOSIS AG PREVIOUSLY RECORDED ON REEL 021965 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 28, 2009
From: NOVOSIS PHARMA AG
To: NOVOSIS AG
Reel/Frame 022162/0452 →
CHANGE OF NAME Recorded Dec 11, 2008
From: NOVOSIS PHARMA AG
To: NOVOSIS AG
Reel/Frame 021965/0001 →
CHANGE OF NAME Recorded Dec 11, 2008
From: NOVOSIS AG
To: ACINO AG
Reel/Frame 021965/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2006
From: FISCHER, WILFRIED; ZIMMERMANN, CLIFTON; HAAS, RUEDIGER
To: NOVOSIS PHARMA AG
Reel/Frame 018655/0672 →
Priority Claims (1)
DE 198 16 143 · Apr 9, 1998 · national
Continuity (3)
Continuation 0968578200 · Oct 10, 2000
Continuation In Part PCTEP990242500 · Apr 9, 1999
Related Publication 20040193089A1 · Sep 30, 2004